TRUP: Trupanion, Inc. Stock

SIC 6324 – Hospital and Medical Service Plans

Valuation
Market Cap ($M) 951.29
Enterprise Value ($M) 932.71
Book Value ($M) 303.72
Book Value / Share 7.26
Price / Book 3.13
NCAV ($M) 82.86
NCAV / Share 1.98
Price / NCAV 11.48

Profitability (mra)
Return on Invested Capital (ROIC) -0.10
Return on Assets (ROA) -0.06
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 1.63
Current Ratio 1.63

Balance Sheet (mrq) ($M)
Current Assets 562.09
Assets 782.95
Liabilities 479.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,108.61
Operating Income -36.27
Net Income -44.69
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 18.64
Cash from Investing 7.64
Cash from Financing 59.13

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-05 13G/A Nielsen Ole 24.00
02-13 13G/A Vanguard Group Inc 8.76 -8.95
02-09 13G/A Capital World Investors 9.70 0.04
02-08 13G Wellington Management Group Llp 5.91 76.07
01-23 13G/A BlackRock Inc. 14.30 0.44
09-21 13G Tarmac DLTFM Ltd 5.10
06-08 13G/A Nine Ten Capital Management LLC 0.00 -100.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA
2023-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPO
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PU
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT P

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-24 87,946 379,215 23.19
2024-04-23 82,418 696,744 11.83
2024-04-22 50,375 282,048 17.86
2024-04-19 139,909 302,101 46.31

(click for more detail)

Similar Companies
PRE – Prenetics Global Limited


Financial data and stock pages provided by
Fintel.io